Sexual Health Services in Community Pharmacy: A Prescriber’s Guide

Sexual health services represent one of the strongest opportunities for community pharmacy independent prescribers. The demand is clear: NHS sexual health clinic waiting times have lengthened, GUM services have been consolidated, and patients — particularly younger demographics — actively seek accessible, discreet, convenient alternatives. Pharmacy sits perfectly in this gap.

The Faculty of Sexual and Reproductive Healthcare (FSRH) and BASHH (British Association for Sexual Health and HIV) both support expanded roles for pharmacist prescribers in sexual health. The regulatory framework exists. The patient demand exists. What is often missing is the operational infrastructure to deliver these services safely at scale.

Scope of Private Sexual Health Services in Pharmacy

Pharmacist independent prescribers can provide a wide range of sexual health services privately. The scope depends on your training, competence, and governance framework:

Why Sexual Health Services Require Specialist Platform Features

Sexual health prescribing has unique requirements that generic platforms often fail to address:

Enhanced Confidentiality

Sexual health has specific legal protections beyond standard medical confidentiality. The NHS (Venereal Diseases) Regulations 1974 (though technically repealed, the principle persists in professional guidance) and the Sexual Health Information Sharing Guidance establish that sexual health information should not be disclosed even to the patient’s GP without explicit consent. Your platform must support:

• Granular consent management — patient chooses whether GP is informed
• Separate communication channels — appointment reminders that do not reveal the nature of the service
• Discrete billing descriptions — payment references that do not identify sexual health services
• Access controls — sexual health records restricted to clinicians directly involved in care

Partner Notification Support

When treating STIs, partner notification is a clinical responsibility (BASHH guidelines). Your platform should support this workflow — either through provider-led notification (you contact partners with patient consent) or patient-led notification (you provide the patient with resources to inform partners). The platform needs to record which notification method was discussed, agreed, and actioned.

Monitoring Schedules

Sexual health services often involve regular monitoring that generic prescribing platforms do not anticipate:

• PrEP monitoring — renal function (eGFR) at baseline, 1 month, then 3-monthly. HIV test at every visit. STI screen at least annually. Hepatitis B status. Bone density consideration for long-term users.
• Contraception reviews — blood pressure monitoring for combined methods, VTE risk reassessment annually, discussion of ongoing suitability
• ED medication reviews — cardiovascular risk reassessment, efficacy review, psychological wellbeing, relationship to lifestyle factors

A platform with configurable monitoring schedules and automated recall — like the tracking features in RxSure — prevents patients falling through gaps in their monitoring pathway.

Clinical Governance for Sexual Health Prescribing

Beyond standard prescribing governance, sexual health services require additional frameworks:

• Safeguarding — sexual health consultations may reveal safeguarding concerns (under-18s, coercion, exploitation). Your SOPs must include clear escalation pathways and documentation requirements.
• Fraser/Gillick competence — if providing services to under-18s, you must assess and document competence for each consultation. The platform should support this assessment workflow.
• Antimicrobial stewardship — STI treatment must follow BASHH guidelines to prevent resistance development. Gonorrhoea treatment in particular follows strict protocols (currently dual therapy with ceftriaxone IM in most cases).
• Outcomes monitoring — track test-of-cure rates for STIs, partner notification success rates, contraception continuation rates, and adverse event rates

Patient Journey: How It Works in Practice

A well-designed sexual health service using a digital platform follows this pathway:

1. Discreet booking — patient books online without phone calls or reception interaction. Service descriptions are clinical but not stigmatising.
2. Pre-screening questionnaire — condition-specific, capturing relevant sexual history, current symptoms, previous STI history, contraception use, and medication list. Completed privately before consultation.
3. Clinical consultation — video or in-person. Structured around BASHH/FSRH clinical guidelines. Platform presents relevant history from pre-screening, reducing repetition for the patient.
4. Testing (if required) — direction to self-sampling kits or local laboratory services. Results managed through the platform with automated patient notification.
5. Prescribing decision — clinical assessment documented, prescription issued (or referral made), safety-netting advice provided and recorded.
6. Follow-up — automated scheduling of test-of-cure, monitoring appointments, or repeat prescription reviews. Patient receives discreet reminders.

Building Patient Trust and Accessibility

Sexual health services in pharmacy succeed when patients feel safe, un-judged, and in control. Platform features that build trust:

• Anonymous initial enquiry options (before formal registration)
• Clear privacy statements visible before booking
• Patient choice over communication method (some patients cannot receive texts at home safely)
• No requirement to attend in person for follow-ups (video/phone options)
• Inclusive language and imagery that does not assume heterosexuality or gender binary

These are not just ethical considerations — they are business considerations. Patients who feel safe refer others. Word-of-mouth is the primary growth driver for discreet services.

Regulatory Landscape

Key regulations and guidelines governing pharmacy sexual health services:

• GPhC Standards for Registered Pharmacies — all five principles apply, with emphasis on Standard 1 (governance) and Standard 2 (staff)
• BASHH clinical guidelines — condition-specific management recommendations, updated regularly
• FSRH guidelines — contraception prescribing, UKMEC (UK Medical Eligibility Criteria) for contraceptive use
• BHIVA/BASHH PrEP guidelines — eligibility criteria, monitoring protocols, and prescribing recommendations
• NICE guidance — NG68 (STIs: condom distribution schemes), PH3 (preventing STIs and under-18 conceptions)
• Safeguarding — Working Together to Safeguard Children (2023), local safeguarding procedures

Frequently Asked Questions

Do I need FSRH membership to prescribe contraception?

FSRH membership is not a legal requirement for prescribing contraception as an independent prescriber. However, you must demonstrate competence. The FSRH Diploma (DFSRH) or equivalent training is the standard route to demonstrating this competence. Without formal sexual health training, your professional indemnity may not cover contraception prescribing, and your clinical governance framework would be difficult to defend at inspection.

Can I prescribe PrEP privately?

Yes. PrEP (tenofovir disoproxil/emtricitabine) is available on private prescription from any independent prescriber with appropriate competence. BHIVA/BASHH guidelines (2023) provide the clinical framework. Key requirements: HIV testing at baseline and every 3 months, renal function monitoring, Hepatitis B screening, and STI screening. The monitoring burden means you need a platform with robust recall and tracking capabilities.

What about sildenafil — isn’t it available OTC?

Sildenafil 50mg was reclassified as Pharmacy (P) medicine in 2018 (Viagra Connect). However, higher doses (100mg), alternative PDE5 inhibitors (tadalafil daily, vardenafil), and patients with complex cardiovascular histories still require prescriptions. Private prescribing in this space adds value through: proper cardiovascular assessment, access to the full formulary of PDE5 inhibitors, titration options, and addressing underlying causes rather than just symptom treatment.

How do I handle under-18 patients?

Under-18s can consent to sexual health services if assessed as Gillick competent (or Fraser competent specifically for contraception). Document your competence assessment at every consultation. Have clear safeguarding pathways — particularly for under-16s, where mandatory reporting considerations may apply. Your platform should flag under-18 patients for enhanced safeguarding documentation.

What monitoring does the platform need to track for these services?

RxSure’s platform supports configurable monitoring schedules — you define what tests or reviews are due and when, and the system tracks compliance and sends recall notifications. For PrEP this means eGFR and HIV testing every 3 months; for contraception, annual BP checks and risk reassessment. The platform flags overdue monitoring so no patient falls through the gaps.

References

1. BASHH. UK National Guidelines on STI Management. Updated 2023. bashhguidelines.org
2. BHIVA/BASHH. Guidelines on the Use of HIV Pre-Exposure Prophylaxis (PrEP). 2023. bhiva.org
3. Faculty of Sexual and Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC). 2023. fsrh.org
4. General Pharmaceutical Council. Standards for Registered Pharmacies. 2024. pharmacyregulation.org
5. HM Government. Working Together to Safeguard Children. 2023. gov.uk